Market advocates cite new DRG plan's flaws as competition tool.
D003365:Costs and Cost Analysis; D003953:Diagnosis-Related Groups; D004465:Economic Competition / Q000331:legislation & jurisprudence; D006278:Medicare / Q000331:legislation & jurisprudence*; D011445:Prospective Payment System / Q000331:legislation & jurisprudence; D014481:United States